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Abstract: OBJECTIVE Patients with chronic stroke have been shown to have failure to release inter-
hemispheric inhibition (IHI) from the intact to the damaged hemisphere before movement execution
(premovement IHI). This inhibitory imbalance was found to correlate with poor motor performance in
the chronic stage after stroke and has since become a target for therapeutic interventions. The logic of
this approach, however, implies that abnormal premovement IHI is causal to poor behavioral outcome
and should therefore be present early after stroke when motor impairment is at its worst. To test this idea,
in a longitudinal study, we investigated interhemispheric interactions by tracking patients’ premovement
IHI for one year following stroke. METHODS We assessed premovement IHI and motor behavior five
times over a 1-year period after ischemic stroke in 22 patients and 11 healthy participants. RESULTS We
found that premovement IHI was normal during the acute/subacute period and only became abnormal
at the chronic stage; specifically, release of IHI in movement preparation worsened as motor behavior
improved. In addition, premovement IHI did not correlate with behavioral measures cross-sectionally,
whereas the longitudinal emergence of abnormal premovement IHI from the acute to the chronic stage
was inversely correlated with recovery of finger individuation. INTERPRETATION These results sug-
gest that interhemispheric imbalance is not a cause of poor motor recovery, but instead might be the
consequence of underlying recovery processes. These findings call into question the rehabilitation strategy
of attempting to rebalance interhemispheric interactions in order to improve motor recovery after stroke.
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Abstract 51 
OBJECTIVE: Patients with chronic stroke have been shown to have failure to release 52 
interhemispheric inhibition from the intact to the damaged hemisphere prior to movement 53 
execution (pre-movement-IHI). This inhibitory imbalance was found to correlate with poor motor 54 
performance in the chronic stage after stroke, and has since become a target for therapeutic 55 
interventions. The logic of this approach, however, implies that abnormal pre-movement-IHI is 56 
causal to poor behavioral outcome, and should therefore be present early after stroke when motor 57 
impairment is at its worst. In a longitudinal study, we investigated interhemispheric interactions 58 
by tracking patients’ pre-movement-IHI for one year following stroke.  59 
METHODS: We assessed pre-movement-IHI and motor behavior five times over a one-year 60 
period after ischemic stroke in 22 patients, and in 11 healthy participants. 61 
RESULTS: We found that pre-movement-IHI was normal during the acute/subacute period, and 62 
only became abnormal at the chronic stage; specifically, release of IHI in movement preparation 63 
worsened as motor behavior improved. In addition, pre-movement-IHI did not correlate with 64 
behavioral measures cross-sectionally, while the longitudinal emergence of abnormal pre-65 
movement-IHI from the acute to the chronic stage was inversely correlated with recovery of 66 
finger individuation.  67 
INTERPRETATION: These results suggest that interhemispheric imbalance is not a cause of 68 
poor motor recovery but instead might be the consequence of underlying recovery processes. 69 
These findings call into question the rehabilitation strategy of attempting to rebalance 70 
interhemispheric interactions in order to improve motor recovery after stroke.  71 
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Introduction 73 
It has been proposed that one contributor to chronic hemiparesis is an imbalanced inhibitory 74 
interaction between the lesioned and intact hemispheres via transcallosal connections. This 75 
interhemispheric-competition model proposes that the two hemispheres, which normally exert 76 
mutual inhibition in healthy individuals, become imbalanced after stroke, and that unopposed 77 
inhibition from the healthy to the damaged side impedes recovery1. This framework is largely 78 
based on a seminal study that showed persistent pre-movement interhemispheric-inhibition (IHI) 79 
from the contra- to ipsi-lesional motor cortex prior to movement execution in patients with 80 
chronic stroke2. This failure to release IHI prior to movement onset (abnormal pre-movement-81 
IHI) correlated with weakness and impaired finger tapping performance2. Influenced by this 82 
stroke-recovery model, numerous studies in the neurorehabilitation field have used different 83 
approaches (e.g. brain stimulation, peripheral stimulation, and transient deafferentation) in an 84 
attempt to down-regulate excitability in the unaffected hemisphere and thus rebalance putative 85 
abnormal interhemispheric-inhibition (see recent studies3,4 and reviews5–7). 86 
The problem with the interhemispheric-competition model is that abnormal pre-87 
movement-IHI has only been described in patients with chronic stroke and relatively mild 88 
impairment. Stinear and colleagues8, using an indirect measure of IHI, recently found no 89 
evidence for hemispheric-imbalance in the first three months after stroke. To date it remains 90 
unclear if imbalanced interhemispheric interactions are present in the context of movement early 91 
after stroke, whether they evolve over time, and if they have any predictive value for motor 92 
recovery. If interhemispheric interactions are normal early after stroke, then designing 93 
rehabilitation strategies based on the interhemispheric-competition model is questionable. Here 94 
in a longitudinal observational study of patients with mild-to-moderate hemiparesis, we 95 
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investigated the evolution of pre-movement-IHI over the first year after stroke and related it to 96 
motor recovery of the hand. To this end, we followed the same inclusion-exclusion criteria and 97 




Twenty-two patients with hemiparesis from first-time ischemic stroke (7 female; mean-102 
age 57.5±16 years, 15 right-handed according to the Edinburgh Handedness Inventory9) were 103 
recruited from three centers (The Johns Hopkins Hospital and Affiliates (JHM), Columbia 104 
University Medical Center (CU), and The University Hospital of Zurich & Cereneo Center for 105 
Neurology and Rehabilitation (UZ)) for a prospective cohort study over the course of four years. 106 
All patients met the following inclusion criteria: 1) First-ever ischemic stroke confirmed by MRI 107 
within the previous 2 weeks; 2) One-sided upper extremity weakness (MRC<5). We excluded 108 
patients with the following criteria: contraindications to magnetic stimulation, age under 21 109 
years, hemorrhagic stroke, space-occupying hemorrhagic transformation, bilateral hemiparesis, 110 
traumatic brain injury, encephalopathy, global inattention, visual-field cut larger than a 111 
quadrantanopia, receptive aphasia, inability to give informed consent or understand the tasks, 112 
major neurological or psychiatric illness that could confound performance/recovery, or a 113 
physical or other neurological condition that would interfere with arm, wrist, or hand function 114 
recovery. See Table 1 for details of patient characteristics. 115 
 We also recruited 11 age-matched healthy control participants (4 female; mean age 64±9 116 
years; all right-handed) at the three centers. All participants gave written consent and the 117 
respective Institutional Research Board at each study center approved all procedures. All 118 
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procedures were in compliance with the Declaration of Helsinki. All patients were tested at five 119 
time points over one-year period (Table 2). 120 
----------------------------- 121 
Table 1 122 
----------------------------- 123 
Assessment of Interhemispheric Inhibition with Transcranial Magnetic Stimulation (TMS)   124 
TMS procedures and IHI assessments. Participants were comfortably seated in an 125 
armchair, arms resting on a pillow and faced a computer monitor. IHI was assessed by a double-126 
pulse paradigm2,10 (Fig 1A), with two figure-of-eight coils (diameters of wings 70mm and 127 
50mm), each connected to a Magstim-200 magnetic stimulator (Magstim, UK). The larger coil 128 
was placed tangentially over the lesioned M1 (for testing stimulus, TS), with the handle oriented 129 
toward the back of the head and laterally at a 45º angle from the midsagittal line. The smaller 130 
coil was oriented perpendicular to midsagittal line over the unaffected M1 (for conditioning 131 
stimulus, CS). For healthy age-matched controls, the CS was always applied to the right M1 and 132 
the TS to the left M1, contralateral to the moving right hand. The positions of the coils on the 133 
skull were adjusted to produce a maximal response in the contralateral first dorsal interosseus 134 
(FDI) muscles (the hotspots). A frameless stereotactic neuronavigation device (Brainsight, 135 
Rogue Research Inc, CA) was used to track coil positions within and across sessions. 136 
Two stimulation conditions were used to calculate IHI: non-conditioned trials (NC: TS-137 
only), where only a TS pulse was delivered, and conditioned trials (C: CS+TS), where a CS 138 
pulse was delivered prior to a TS pulse with an inter-stimulus interval (ISI) of 10ms. Conditioned 139 
and unconditioned trials were intermixed and randomized throughout the testing session.  140 
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IHI was assessed in two contexts: at rest (resting) and during movement preparation (pre-141 
movement). Following a previous study, IHI at rest was obtained in order to determine the 142 
stimulation parameters for pre-movement-IHI2. For resting-IHI, intensities of TS and CS were 143 
first set at the minimum maximal-stimulator-output (MSO) that produced a contralateral motor-144 
evoked-potential (MEP) with amplitude 0.5-1mV. The CS intensity was then adjusted to produce 145 
a ~50% reduction in TS-MEP amplitude. The resting-IHI assessment consisted of a block of 36 146 
trials with 18 each for NC and C stimulation. 147 
 During the pre-movement-IHI task, while the participant performed a simple reaction-148 
time (RT) task, a TMS pulse was then delivered on each trial at four possible epochs: 20, 50, 80, 149 
and 95% of each participant’s RT (see the section below, Fig. 1B). The TS intensity was 150 
determined in the same way as for resting-IHI. To assess the CS-intensity in the context of 151 
movement execution, participants were asked to perform the same RT task when double-TMS 152 
pulses were delivered at an estimated 50% of RT on each trial, and CS-intensity was adjusted to 153 
the level approximating 50% of the TS-MEP. This adjustment was to probe the largest possible 154 
dynamic range of CS modulation during pre-movement-IHI testing. As described previously2, 155 
when probed at different times during the RT, a healthy control’s typical IHI curve shows an 156 
initial reduction, followed by increases of MEP when stimulation is delivered closer to 157 
movement onset, i.e. interhemispheric-inhibition switches to facilitation (release-of-inhibition). 158 
A total of six blocks, with 24 pre-movement-IHI trials per block, were run in each testing 159 
session, with 18 pulses per stimulation/time-epoch condition. Sessions were not run if patients 160 
could not abduct their index finger or if the stimulation intensity was too high to obtain both 161 
resting- and pre-movement-IHI (required ≥90 MSO to elicit an MEP >0.5mV). These patients 162 
were still included in the study if IHI could be obtained in subsequent visits. 163 
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Resting motor threshold (rMT) for both FDIs were determined as the minimal TMS 164 
intensity required to evoke MEPs of ~50µV (peak-to-peak amplitude) in the targeted muscle on 165 
five out of ten consecutive trials.  166 
Because MEP amplitudes increase in the moving effector immediately before movement 167 
onset, leading to large MEP that can mask the true size of release-of-inhibition (or contralateral 168 
facilitation), we compared the MEP amplitudes recorded during the pre-movement-IHI 169 
procedure with maximal amplitudes obtained in each participant using assessment of active 170 
corticospinal tract (aCST). This was done with 18 single pulses delivered at 100% MSO with an 171 
inter-stimulus interval (ISI) of 5-7s, while the participant was actively contracting the 172 
contralateral FDI at a constant level of 20% of their maximum voluntary contraction force. 173 
EMG recording. Electromyogram (EMG) activity was monitored from surface electrodes 174 
placed over the FDI in both hands. Three EMG systems were used at the three sites: SX230-100 175 
and K800, Biometrics Ltd. (CU); AMT-8; Bortec Biomedical Ltd. (JHM); and Telemyo desk 176 
receiver, Noraxon (UZ). The Biometrics EMG signal was sampled at 1000Hz, amplified 1000x, 177 
band-pass filtered at 15-450Hz; the AMT-8 EMG signal was sampled at 1000Hz, amplified 178 
1000x, band-pass filtered at 10-1000Hz; and the Noraxon EMG was sampled at 1500Hz, 179 
amplified 500x, band-pass filtered at 15-450Hz. EMG signals were used to determine RTs and 180 
MEP amplitudes (see Measures of pre-movement-IHI section). 181 
----------------------------- 182 
Figure 1 183 
----------------------------- 184 
Simple reaction-time task for pre-movement-IHI assessment 185 
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 Pre-movement-IHI was assessed while participants performed a simple RT task. The 186 
participants were instructed to make a voluntary index-finger abduction in response to a GO-cue 187 
(green dot). Patients used their paretic hand, while healthy volunteers always performed the task 188 
with their right hand. The GO-cue was displayed on the monitor for 2 seconds, and disappeared 189 
at the end of the trial. The inter-trial interval (ITI) was 5 seconds plus 0-2 seconds of jitter to 190 
prevent anticipation. 191 
 Prior to the IHI procedure, each participant performed the simple reaction task for 30 192 
trials to determine their average RT. The last 15 trials were used to calculate the RT. 193 
Stroke-related behavioral assessments 194 
All patients’ and controls’ upper-extremity motor impairment was determined with the 195 
Fugl-Meyer assessment (FMA)11, following the same schedule as pre-movement-IHI. Hand 196 
function was also tested within ±4.6 days from the TMS experiment, as previously described12. 197 
Briefly, participants were instructed to move each finger in isolation on an ergonomic device that 198 
measures the isometric force generated by each digit. A Strength Index was calculated from the 199 
maximum voluntary force (MVF) of individual finger flexion, normalized to the MVFs on the 200 
non-paretic side at one-year time point. An Individuation Index was derived from the activation 201 
in the non-instructed fingers as a function of force produced by the instructed finger pressing to 4 202 
levels of target forces. 203 
Measures of pre-movement-IHI 204 
EMG was used to measure RT and peak-to-peak amplitudes of the MEPs elicited in FDI 205 
of both hands. Both RTs and MEPs were identified using custom-made MATLAB scripts (The 206 
MathWorks, Inc., Natick, MA) from the EMG recordings. The RT was manually identified with 207 
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the following criteria: peak-to-peak waveforms of EMG activity >100µV and lasting longer than 208 
50ms following the GO-cue. 209 
The following trial types were excluded from further analysis: 1) Trials with any 210 
background EMG activity >20µV in the 150ms window preceding the TMS pulse in either FDI; 211 
2) MEP size <50µV; 3) MEP occurrence after movement onset; 4) RT >1000ms. An analysis of 212 
the background pre-trigger EMG across different TMS epochs was also conducted to rule out the 213 
potential influence of systematic differences in background EMG on the pre-movement-IHI 214 
results. 215 
Resting and pre-movement-IHI was computed as the ratio C/NC. An IHI-ratio of 1 216 
indicates no interhemispheric-inhibition. To prevent averaging epochs with too few MEP 217 
observations, a minimum of 9 good MEPs (1/2 of the total count) was required to compute the 218 
ratio. A good TS-MEP was defined as: 1) No background EMG activity in the 150ms window 219 
before the TMS pulse; 2) The MEP occurred before movement onset; 3) Peak-to-peak amplitude 220 
was >50µV; 4) Distinct movement is detectable (EMG>100µV for >50ms) within 1000ms after 221 
GO-cue. TMS timing epochs with <9 good MEPs were counted as missing values. To evaluate 222 
the reproducibility of the IHI-ratio as the main dependent variable in this study, we computed its 223 
Cronbach’s alpha13,14. Mathematically, alpha is equivalent to the averaged split-half correlation 224 
of all possible splits of the existing data: .  225 
To assess the evolution of IHI during movement preparation, we derived three other 226 
measures: , , 227 
and . ΔIHI therefore reflects the amount of release-of-228 
interhemispheric-inhibition during movement preparation. A value of ΔIHI=0 indicates no 229 
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modulation of inhibition15; while a positive value implies a release-of-inhibition during 230 
movement preparation. Hereinafter, we will use ΔIHI as an operational definition of pre-231 
movement-IHI to refer to the level of release-of-inhibition prior to movement onset. 232 
Statistical analysis 233 
Data analysis was done with custom-written MATLAB and R (R Core Team, 2017) 234 
routines. Given that there were missing sessions (on average, each patient completed 3.4 sessions 235 
and each healthy control completed 3.5 sessions, out of a total of 5), we used two analysis 236 
approaches: 1) For the primary analysis, we assumed missing ΔIHI values arose at random 237 
(MAR), and used linear mixed-effects models implemented in the lme4 package in R16 to test for 238 
changes in the neurophysiology and behavioral measures over time, with a random-factor of 239 
Subject, and fixed-factors of Time-Point (five time-points from W1-W52, or acute/subacute vs. 240 
chronic), Hand-Condition (paretic, non-paretic, and/or control), and/or TMS-Epoch (early vs. 241 
late TMS timing). 2) Because there are cases where data were missing due to severity of 242 
impairment, specifically when there was no reliable finger abduction and/or MEP at a given 243 
assessment session, there was a concern about the possibility of a systematic relationship 244 
between pre-movement-IHI and missingness. We therefore conducted a sensitivity analysis by 245 
imputing missing values under different data-generating mechanisms. Specifically, we 246 
implemented the assumptions of either no-dependency or strong-dependency between pre-247 
movement-IHI and the severity of initial impairment (Figure 3D-E). No-dependency mimics the 248 
MAR assumption of the mixed-model, with imputed samples drawn from N~(μ(t,patient), σ(t,patient)) , 249 
where μ(t,patient) and σ(t,patient) are estimated from patient data at each time point; while strong-250 
dependency represents a scenario in which severely affected patients have ΔIHI values centered 251 
at 0, with imputed samples from N~(0, σpatient), where σpatient is estimated from all patients’ data. 252 
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For each dataset containing imputed values, we fit the linear mixed-model as specified above. 253 
ANOVA tests for sensitivity analyses were conducted by pooling significance tests of multiply-254 
imputed datasets17. 255 
For behavioral results, we included all available behavioral data, including the sessions in 256 
which we could not obtain IHI. 257 
 258 
Results 259 
We tested a total of 22 patients from the acute to chronic stages after stroke and 11 healthy 260 
controls. Each participant was expected to undergo five testing sessions over the course of a one-261 
year period. One patient appeared to meet initial inclusion criteria, but was later found to have 262 
bilateral strokes and was excluded from further analysis. The final analysis included a total of 263 
110 pre-movement-IHI sessions from 21 patients and 11 controls. Thirteen patients and 8 264 
controls completed ≥3 sessions. The distributions of assessment time and missing data are 265 
presented in Table 2. Non-tested sessions were treated as missing data and all available data were 266 
used in the statistical analyses. The data showed good reliability for the major dependent 267 
variable, IHI-ratio, for both patients and controls (α=0.74 and 0.79 for patients and controls; 268 
Methods). Figure 2 shows the distribution of lesions defined using Diffusion Tensor Images 269 
(details reported in our earlier publication12). 270 
----------------------------- 271 
Figure 2 and Table 2 272 
----------------------------- 273 
Pre-movement-IHI changed from normal to abnormal as paresis improved from the acute to 274 
the chronic stage 275 
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 Our main goal was to determine how IHI prior to movement onset evolves over the first 276 
year after stroke and how this relates to motor recovery. Figure 3A shows a representative 277 
patient’s IHI curves at the acute/subacute and chronic stages, as compared to a healthy age-278 
matched control. Figure 3B-C show the group data for controls and patients. Visual inspection of 279 
these curves suggests that, consistent with the previous report by Murase and colleagues2, 280 
patients in the chronic stage had an abnormal IHI pattern, characterized by the absence of 281 
release-of-inhibition at movement onset. Crucially, however, in the acute/subacute period (W1-282 
12) release-of-IHI at movement onset in patients did not appear to differ from controls. 283 
Specifically, the IHI-ratio at weeks 1-12 post-stroke increased over the movement-preparation 284 
interval, approaching a ratio of 1 at later stimulation epochs (80-95% RT), indicating a level of 285 
release-of-inhibition prior to movement onset similar to healthy controls.  286 
Given that in previous reports, and corroborated here, the post-stroke abnormality in pre-287 
movement-IHI is most apparent at movement onset, our statistical analyses focused on ΔIHI, as 288 
in prior studies15,18. ΔIHI is the difference between IHILATE-EPOCH and IHIEARLY-EPOCH, which 289 
captures the level of release-of-IHI immediately prior to movement onset (Methods). An 290 
ANOVA using a mixed-effects model for ΔIHI yielded a significant Week × Group (patients vs. 291 
controls) interaction (χ2=4.59, p=0.03). The evolution of ΔIHI from the acute/subacute to the 292 
chronic stage after stroke clearly showed that at earlier stages (W1-12), patients and controls 293 
were similar (t(21) = 0.50, p = 0.62), while the two groups started to diverge from W24 onward 294 
(t(31) = 3.30, p = 0.0025) (Fig. 3D). Our sensitivity tests also indicate that this trend is robust to 295 
the differences in the data-generating mechanisms considered (p=0.028 for MAR and p=0.10 for 296 
informed missingness, Fig. 3D-E, Methods). To directly compare ΔIHI in the acute versus the 297 
chronic stage, we pooled data into two Time-periods: mean(W1-12) (acute/subacute for patients) 298 
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and mean(W24-52) (chronic for patients). This data pooling was further supported by our 299 
observation that there was no difference in patients’ ΔIHI from W1-12 (p=0.17), or from W24-52 300 
(p=0.70). The mixed-effects model with Time-period and Group (patients vs. controls) as fixed 301 
factors showed a significant interaction (χ2=6.68, p=0.01). These results show that patients’ pre-302 
movement-IHI progressed from normal in the acute/subacute period to abnormal in the chronic 303 
stage in the case of mild-to-moderate paresis.   304 
----------------------------- 305 
Figure 3 306 
----------------------------- 307 
The development of abnormal pre-movement-IHI was inversely correlated with the extent of 308 
finger individuation recovery 309 
Our cohort of patients was mild-to-moderately impaired in the acute stage (FMAINITIAL 310 
Mean = 41±22, Table 1). Motor recovery was quantified using three behavioral measures: FMA, 311 
Strength and an Individuation Index for finger (ability to move digits independently; Methods)12. 312 
All three measures showed good early recovery (Strength: χ2=28.07, p<.001, Individuation: 313 
χ2=13.64, p<0.001, and FMA: χ2=28.07, p<.001), but then plateaued after the subacute stage 314 
(Fig 3). 315 
----------------------------- 316 
Figure 4 317 
----------------------------- 318 
We then sought to determine if there was any correlation between abnormal pre-319 
movement-IHI and motor behavior.  To address this question, we first examined the cross-320 
sectional correlation between ΔIHI and all three behavioral measures at both the acute/subacute 321 
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and chronic stages; none of the correlations were significant with the null value (0) lying within 322 
95% CI’s (Table 3). Thus there was no clear relationship between abnormal pre-movement-IHI 323 
with strength, individuation, or motor impairment at any time point.  324 
----------------------------- 325 
Table 3 326 
----------------------------- 327 
 Both the opposite longitudinal time-courses for motor recovery and development of 328 
abnormal pre-movement-IHI, and the lack of significant cross-sectional correlation between the 329 
two, suggest that the pre-movement-IHI abnormality was not causally related to behavioral 330 
impairment. Instead, the emergence of abnormal pre-movement-IHI (failure-to-release inhibition 331 
during movement preparation) may be a marker for underlying recovery processes (see 332 
Discussion). To address this alternative possibility, we examined the correlation between 333 
longitudinal motor-function recovery (change in behavior) and the emergence of the failure-to-334 
release IHI (reduction in ΔIHI) from the acute/subacute to the chronic stages. We found a strong 335 
negative correlation between the reduction of ΔIHI and the amount of improvement in the 336 
Individuation Index (r=-0.73, p=0.003, 95% CI: [-0.91, -0.33]). This suggests that the emergence 337 
of failure-to-release IHI during movement preparation and poor finger-individuation recovery 338 
share a latent cause. We did not find a significant correlation between changes in ΔIHI and 339 
changes in the Strength Index (r=0.22, p=0.44, 95% CI: [-0.35, 0.67]; Fig. 5). This observation is 340 
consistent with the fact that by week 52 at the group level, patients’ strength was not far from 341 
healthy levels (t(26)=1.43, p=0.16), but finger individuation was (t(26)=2.43, p=0.02). 342 
----------------------------- 343 
Figure 5 344 
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----------------------------- 345 
Other TMS and behavioral measures 346 
 In addition to pre-movement-IHI, we also measured the participants’ rMT, aCST, and 347 
resting-IHI for the FDI muscle (Methods). Results from these measures are reported in Table 4. 348 
Consistent with the previous literature2,19, IHIREST in patients and controls did not differ. Patients 349 
and controls had comparable TS- and CS-stimulation intensities for both resting- and pre-350 
movement-IHI. For rMT, we included sessions when pre-movement-IHI was not obtainable, and 351 
consistent with prior reports8,20, the results showed higher rMT on the lesioned hemsphere, 352 
reflecting lower level of M1 output at acute-subacute stages in severely-impaired patients. 353 
 To ensure our pre-movement-IHI results were not due to high MEP amplitudes, 354 
especially during the later TMS-epochs, we compared the MEP sizes obtained from aCST with 355 
the single-pulse TS at late TMS epochs (80 and 95% RT; Methods). If TS-MEPs approach the 356 
MEP amplitudes of the aCST, when MEP amplitudes are expected to be near-maximal, the 357 
amount of IHI modulation during movement preparation could lack sufficient dynamic range or 358 
be masked. We found, however, that most late-epoch MEP amplitudes were lower than those 359 
obtained during the aCST assessment (see statistics in Table 4). 360 
----------------------------- 361 
Table 4 362 
----------------------------- 363 
 It might be posited that one way that failure-to-release inhibition might influence 364 
behavior is to prolong the RT. We therefore examined the relationship between the RT and pre-365 
movement-IHI in the simple RT task. RTs in patients were prolonged compared to controls (Fig. 366 
6A-B, χ2=9.19, p=0.002), but this prolongation was not linked to changes in pre-movement-IHI: 367 
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there was no interaction with ΔIHI and RT (χ2=0.31, p=0.58). 368 
 To rule out the possibility of background EMG influencing the observed pre-movement-369 
IHI patterns, we also performed a mixed-effect model analyses on pre-trigger EMG (Methods). 370 
Results showed that background EMG was higher in healthy controls (χ2=5.46, p=0.019), and 371 
decreased over time in both groups (χ2=45.23, p= ), possibly due to participants 372 
becoming more acquainted with the testing procedure (Fig. 6C-D). Critically, there was no main 373 
effect of conditioned (C) vs. non-conditioned (NC) trials, nor any interaction between group and 374 
any other factor. Thus, differences in background EMG cannot explain the pre-movement-IHI 375 
findings. 376 
 Finally, age did not influence the main dependent variable ΔIHI (χ2=0.53, p=0.47), nor 377 
did it interact with Week (χ2=4.73, p=0.09). Similarly, age also did not modulate the behavioral 378 
outcome variables in our cohort: Strength, Individuation, FMA, and ARAT. 379 
----------------------------- 380 




In a longitudinal multi-center study, we tracked the evolution of pre-movement-385 
interhemispheric-inhibition (IHI) from stroke onset up to one year. We used a double-pulse TMS 386 
paradigm to test patients and healthy controls at five time-points: week 1, 4, 12, 24, and 52. We 387 
also tracked patients’ finger strength and individuation, and overall motor impairment (FMA). 388 
We found that release-of-IHI prior to movement onset was normal in the acute/subacute period, 389 
and became abnormal in the chronic stage. Conversely, behavioral outcomes were most impaired 390 
 20 
in the acute/subacute period and improved over time to reach plateau in the chronic stage. In 391 
addition to these opposite longitudinal trends for the physiological and behavioral measures, we 392 
found no significant cross-sectional correlations between pre-movement-IHI and behavioral 393 
measures in the patients (strength and individuation). The only significant correlation was an 394 
inverse relationship between the development of abnormal pre-movement-IHI from the 395 
acute/subacute to the chronic stage after stroke (i.e., the emergence of the failure-to-release IHI 396 
prior to movement onset) and the amount of recovery in finger individuation across the same 397 
time period.  398 
 In the seminal study by Murase and colleagues2, impaired pre-movement-IHI was found 399 
in nine patients with chronic stroke. This study has become highly influential and, in our view, 400 
was prematurely interpreted by the overall neurorehabilitation field as suggesting a possible 401 
causal relationship between IHI and recovery of motor impairment. This interpretation is 402 
problematic because: A) Pre-movement-IHI is only one kind of inter-hemispheric measure; it is 403 
possible to assess interhemispheric-inhibition at other inter-stimulus intervals or 404 
interhemispheric-facilitation21. B) Pre-movement-IHI is only obtainable in patients with 405 
detectable MEPs and finger movements; it cannot be assessed in patients with more severe motor 406 
deficits. C) The study by Murase and colleagues had a small sample of patients at only one time-407 
point in the chronic stage, which makes inference about changes over time, or recovery, 408 
impossible. The over-interpretation of the Murase et al. results led in turn to a large number of 409 
studies that attempted, or claimed, to rebalance IHI using non-invasive brain stimulation (NIBS) 410 
in the acute and chronic stages after stroke22–26. What should have been established first, in our 411 
view, is the time-course of the development of pre-movement-IHI abnormality from the 412 
acute/subacute period to the chronic stage.  413 
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The critical finding reported here is that in the acute/subacute period, in those patients 414 
that could be assessed with this TMS technique, we found normal modulation of pre-movement-415 
IHI despite their motor deficits. Failure-to-release pre-movement-IHI only emerged in the 416 
chronic stage, whereas the behavioral measures all improved over the same time period. This 417 
contrast makes any claim to a causal relationship between abnormal pre-movement-IHI and the 418 
motor deficit implausible. Adding to this, we found no significant cross-sectional correlations 419 
between pre-movement-IHI and severity of paresis, assessed by FMA, Strength, or 420 
Individuation. Admittedly, given the limited statistical power, we cannot definitively rule out the 421 
possibility of an association between pre-movement IHI and a clinical measure. Interestingly 422 
though, a recent meta-analysis27 of 112 TMS studies concluded that “there is no clear evidence 423 
for hyper-excitability of the unaffected hemisphere” in either the acute or chronic phases after 424 
stroke. Nevertheless, it is important to note that the interpretation of our results, as well as of 425 
previous investigations, should be limited to those patients for which it is possible to assess pre-426 
movement-IHI and/or obtain MEPs, i.e. those with mild-to-moderate motor deficits. Therefore, it 427 
remains unclear what the interhemispheric-interaction would be for patients with more severe 428 
motor deficits. 429 
It would be puzzling, however, if pre-movement-IHI were to be abnormal in the acute 430 
period in severe patients given that our mild-to-moderate patients showed improvement from 431 
paresis as IHI became worse. Thus, from parsimony, it would seem that the interhemispheric-432 
competition model would not be a satisfactory causal explanation even in patients with severe 433 
motor deficits. Unfortunately, methodological limitations prevent us from going beyond this 434 
speculation.  435 
The inverse correlation between the emergence of abnormal pre-movement-IHI from the 436 
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acute/subacute to chronic stages and recovery of individuation suggests that, rather than any 437 
direct causal relationship between them, the development of an abnormal pattern of ΔIHI over 438 
time might provide an indirect measure of the state of longitudinal recovery. This would mean 439 
that the amount of reduction in ΔIHI might reflect a less optimal form of reorganization, such as 440 
a reliance on contra-lesional corticoreticular projections28,29, or possibly the consequence of 441 
decreasing use of the paretic hand in dexterity-requiring tasks. Both possibilities are consistent 442 
with the finding that finger-individuation did not fully recover even at one year after stroke (Fig. 443 
4B). We cannot disambiguate these two possibilities in this study. However, here we show: 1) 444 
There is no cross-sectional correlation between pre-movement-IHI and behavior; 2) Behavior 445 
gets better as pre-movement-IHI gets worse; 3) The emergence of abnormal pre-movement-IHI 446 
is correlated with poor finger-individuation recovery. These results together suggest that the 447 
abnormal interhemispheric interaction in the chronic stage might be the consequence of, and a 448 
marker for, the state of recovery of the brain rather than the cause of the initial impairment. 449 
Therefore, it is questionable that interhemispheric-imbalance should be a therapeutic target.  450 
 The results presented here challenge the validity of the interhemispheric-competition 451 
recovery model. This is important given that in the past decade, numerous studies have used 452 
NIBS in an attempt to down-regulate the contralesional hemisphere to promote recovery: from 453 
2005-2016 there were 45 published clinical trials using cathodal tDCS25 and 25 trials up to May 454 
2014 using rTMS26. The lasting impact of the model is apparent in a recent influential 455 
perspective by Di Pino and colleagues7, in which they introduce a hybrid recovery model that 456 
combines vicariation in the ipsilesional-hemisphere with interhemispheric-competition. Of note, 457 
our results do not negate the fact that on occasions, NIBS over the ipsi, contra or bilateral 458 
hemisphere have shown beneficial effects3,4. What our results do indicate, however, is that any 459 
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beneficial effect of NIBS is not likely operating via an interhemispheric-inhibition mechanism, at 460 
least for patients with mild-to-moderate hemiparesis.  461 
 In conclusion, the results reported here cast doubt on the validity of the interhemispheric-462 
competition model. Future investigations using non-invasive brain stimulation, or other 463 
interventions, such as peripheral nerve stimulation, to improve recovery following stroke will 464 
require alternative mechanistic justification. 465 
 466 
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Table 1. Patient characteristics: gender, age (years), handedness, paretic side, initial FMA 553 
(Fugl-Meyer upper limb score, maximum = 66), and initial MoCA (Montreal Cognitive 554 





Side Initial FMA 
Initial 
MoCA 
1 M 57 R R 48 27 
2 M 66 R L 65 25 
3 M 65 R L 30 25 
4 F 66 R L 60 19 
5 F 63 L L 57 26 
6 M 56 R L 64 24 
7 F 64 L R 20 16 
8 F 60 L R 55 21 
9 M 64 L L 63 25 
10 M 24 R L 35 23 
11 F 67 R R 16 23 
12 M 42 L R 54 25 
13 M 35 R L 4 29 
14 M 48 L L 16 25 
15 M 74 R R 5 25 
16 F 80 R R 9 24 
17 F 64 R L 58 19 
18 M 22 R R 63 27 
19 M 84 R R 30 26 
20 M 53 L R 30 29 
21 M 54 R L 59 21 
22 M 58 R L 61 23 
 556 
  557 
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Table 2. Distribution of assessment time and data obtained. The first two rows are the number of 558 
weeks and days post-stroke at each time point of assessment. The following two rows are patient 559 
counts with obtained data. The following six categories are counts of missing data for various 560 
reasons: MEP count < 9 at early TMS epochs (20 and 50% RT) are likely due to lack of big 561 
enough MEP size (>50 µV), whereas those at late TMS epochs (80 and 50% RT) are likely due 562 
to TMS pulses occurring during the movement; “No MEP” or “TS > 90 MSO” can sometimes 563 
be overlapping with “No reliable movement (index finger abduction)” count in cases of complete 564 
plegia; “Other missing” cases include data missing with random reasons: missed the time-565 
window, patient dropped out of the study, patients refused to continue the session, or technical 566 
issues during the session. Percentages out of the total N = 21 are presented in parentheses. 567 
 568 
Total N = 21 W1 W4 W12 W24 W52 
Number of weeks post stroke 1-2 4-6 12-14 24-26 52-54 
Number of days post stroke 12± 3 34±5 93±8 184±12 369±10 
Number of patients      
IHI obtained 10 (48%) 13 (62%) 14 (67%) 18 (86%) 16 (76%) 
ΔIHI obtained 8 (38%) 11 (52%) 12 (57%) 16 (76%) 15 (71%) 
MEP count < 9 (early TMS epochs) 0 (0%)  1 (5%) 1 (5%) 0 (0%) 0 (0%) 
MEP count < 9 (late TMS epochs) 2 (10%) 1 (5%) 1 (5%) 2 (10%) 1 (5%) 
No MEP 4 (19%) 2 (10%) 0 (0%) 0 (0%) 0 (0%) 
TS > 90 MSO 3 (14%) 4 (19%) 2 (10%) 0 (0%) 0 (0%) 
No reliable movement 6 (29%) 3 (14%) 2 (10%) 0 (0%) 0 (0%) 
Other missing 2 (10%) 0 (0%) 3 (14%) 3 (14%) 5 (24%) 
569 
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Table 3. Cross-sectional correlations between release of IHI prior to movement onset (ΔIHI) 570 
and behavioral measures, FMA, and Strength and Individuation Indices, at acute/subacute and 571 
chronic stages. Table shows Pearson-r values; parentheses represent the 95% confidence 572 
interval for each correlation coefficient. 573 
FMA Strength Individuation 
Acute/subacute 

















Table 4. Other basic TMS measures. Reported here are mean and standard deviations of IHI at 575 
rest (IHIrest), CS and TS stimulation intensities for resting and pre-movement-IHI, MEP 576 
amplitude in patients for active corticospinal track integrity (aCST) assessed with 100% MSO, 577 
TS at 95 and 80% of RT, and resting motor threshold (rMT) in patients and controls. Independent 578 
samples t-tests were done between patients and controls for IHIrest and CS and TS intensities at 579 
each time point. MEP amplitudes were compared between aCST and TS at each time point 580 
among patients. Comparison of rMT were done between paretic vs. non-paretic hands in 581 
patients, and dominant vs. non-dominant hands in healthy controls. 582 






Week 1 4 12 24 52 1 4 12 24 52 































     
CS Stimulus Intensity (% MSO)      










Control 58 (8) 49 (10) 49 (4) 56 (14) 56 (15)      
TS Stimulus Intensity (% MSO)      










Control 59 (9) 54 (7) 54 (8) 63 (11) 60 (12)      
IHIpremove CS Stimulus Intensity (% MSO)      










Control 56 (8) 50 (10) 49 (4) 56 (14) 56 (15)      
TS Stimulus Intensity (% MSO)      










Control 52 (7) 48 (6) 50 (6) 58 (9) 53 (12)      











     
TS 











































Patient rMT Paretic vs. non-paretic 












42 (11) 40 (9) 40 (9) 40 (10) 40 (10)  
Control      Paretic vs. control 
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Figure 1. Schematic illustration of the pre-movement Interhemispheric Inhibition (IHI) 586 
paradigm. (A) A Test Stimulus (TS) was delivered over the lesioned hemisphere, and a 587 
Conditioning Stimulus (CS) was applied over the intact hemisphere prior to index finger 588 
abduction of the paretic hand (or right hand in healthy age-matched controls). In non-589 
conditioned (NC) trials only the TS was delivered, while in conditioned (C) trials the CS 590 
preceded TS by 10ms. EMG signals were recorded from the first dorsal interosseous muscle 591 
(FDI) of the moving hand; (B) TMS pulses were delivered at four timing epochs relative to the 592 
individual’s mean reaction time, estimated from a simple-reaction task. 593 
Figure 2. Lesion distribution of patients (N = 21). Averaged lesion distribution mapped to JHU-594 
MNI space30, with lesion flipped to one hemisphere. Color bar indicates patient count. 595 
Figure 3. Release of IHI prior to movement onset. (A) IHI curves for a representative patient 596 
and a healthy control. These exemplar IHI profiles illustrate the normal release of IHI in 597 
patients at the acute/subacute stage, comparable to control subjects, and the lack of normal 598 
release of IHI during the chronic period; (B) Overall mean IHI curves for healthy controls. 599 
Since there were no differences over time in pre-movement-IHI in controls (mixed-effects model 600 
with Week and TMS-Timing as fixed factors showed no significant effect of Week, χ2 = 0.067, p 601 
= 0.80, but significant main effect of TMS-Timing, χ2 = 22.28, p < 0.001), we averaged control 602 
data across weeks. (C) IHI curves for each time point over the one-year period for patients; (D) 603 
Evolution of ΔIHI for patients and controls over the one-year period. Patient showed close to 604 
control level of ΔIHI in the actue/subacute periods (W1-12), but their ΔIHI’s became abnormal 605 
at the chronic stage. Shaded plots in grey and red are sensitivity analysis with two imputation 606 
schemes with MAR and informed-missingness cases respectively, where missing not at random 607 
(MNAR) cases are imputed with 1000 samples from N~(μ(t,patient), σ(t,patient)) or N~(0, σpatient). 608 
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μ(t,patient) and σ(t,patient) are estimated from patients data at each time point and σpatient is estimated 609 
from all patients’ data. (E) Distribution of p-values from sensitivity analysis with multiple 610 
imputation for the MAR and informed-missingness cases. (F) Change of IHI level at different 611 
movement preparation epochs in patients from the acute/subacute to chronic stage after stroke. 612 
There was a significant interaction of IHIEARLY-EPOCH vs. IHILATE-EPOCH or acute/subacute and 613 
chronic stages (χ2 = 4.34, p = 0.037), but no differences when comparing across acute/subacute 614 
vs. chronic stages for IHIEARLY-EPOCH (t(14) = 0.75, p = 0.47) or IHILATE-EPOCH (t(14) = 1.69, p = 615 
0.11). Means and variances in all plots were estimated by mixed-models. 616 
Figure 4. Recovery curves for behavior measures of hand function over one-year period, from 617 
week 1-52. (A) Strength Indices, (B) Individuation Indices, (C) FMA. Means and variances are 618 
estimated by mixed-model. 619 
 Figure 5. Correlations between the reduction of pre-movement-IHI (ΔIHI) from acute/subacute 620 
to chronic stages and the amount of behavioral recovery: (A) Strength, (B) Individuation. x- and 621 
y-axes are the mean differences between chronic and acute/subacute behavior measures andΔ622 
IHI, respectively. 623 
Figure 6. Other behavioral and physiological measures in pre-movement experiments. Reaction 624 
time (RT) for patients (A) and controls (B) at different TMS timing during movement preparation 625 
across the one-year period. RTs for controls were overall faster than patients. Background EMG 626 
for patients (C) was overall lower than that in controls (D), but was at a similar level for 627 
conditioned vs. non-conditioned TMS stimulation. 628 
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